Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor

The Dendritic Cell System and its Role in Immunogenicity

Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,659

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

Caux, C., Dezutter‐Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,551

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293

Induction of tolerance by IL-10-treated dendritic cells

Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,245

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.

Caux, C., Vanbervliet, B., Massacrier, C., Dezutter‐Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.695 · Cited by 920

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.87 · Cited by 824

Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

Zhou, L., & Tedder, T. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3821 · Cited by 751

Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1)

Kawasaki, E. S., Ladner, M. B., Wang, A. M., Arsdell, J. V., Warren, M. K., Coyne, M. Y., Schweickart, V. L., Lee, M.-T., Wilson, K. J., Boosman, A., et al. (1985) · Science · doi:10.1126/science.2996129 · Cited by 523

Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective “Arming” of Tumor Antigen-Specific CTL

Nelson, D. J., Mukherjee, S., Bundell, C. S., Fisher, S. A., van Hagen, D., & Robinson, B. W. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5557 · Cited by 65

Does Postoperative Complication Have a Negative Impact on Long-Term Outcomes Following Hepatic Resection for Colorectal Liver Metastasis?: A Meta-Analysis

Matsuda, A., Matsumoto, S., Seya, T., Matsutani, T., Kishi, T., Yokoi, K., Wang, P., & Uchida, E. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2972-z · Cited by 64

Inflammation and Stem Cells in Gastrointestinal Carcinogenesis

Quante, M., & Wang, T. C. (2008) · Physiology · doi:10.1152/physiol.00031.2008 · Cited by 64

Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.

Roth, M. D., Gitlitz, B. J., Kiertscher, S. M., PARK, A. N., Mendenhall, M. A., Moldawer, N. P., & Figlin, R. A. (2000) · PubMed · Cited by 63

Gangliosides inhibit the development from monocytes to dendritic cells

Wölfl, M., Batten, W. Y., Posovszky, C., Bernhard, H., & Berthold, F. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.02006.x · Cited by 63

Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma

Bella, S. D., Nicola, S., Brambilla, L., Riva, A., Ferrucci, S. M., Presicce, P., Boneschi, V., Berti, E., & Villa, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.011 · Cited by 63

Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.

Becker, Y. (2006) · PubMed · Cited by 63

Dendritic cells dysfunction in tumour environment

Bennaceur, K., Chapman, J. A., Brikci-Nigassa, L., Sanhadji, K., Touraine, J. L., & Portoukalian, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.017 · Cited by 62

Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma

Chauhan, A., House, M. G., Pitt, H. A., Nakeeb, A., Howard, T. J., Zyromski, N. J., Schmidt, C. M., Ball, C. G., & Lillemoe, K. D. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00262.x · Cited by 60

Autocrine CSF-1 and CSF-1 Receptor Coexpression Promotes Renal Cell Carcinoma Growth

Weinmann‐Menke, J., Kriegsmann, J., Schimanski, C. C., Schwartz, M. M., Schwarting, A., & Kelley, V. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1232 · Cited by 60

Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations

Dineshkumar, T., Ashwini, B., Rameshkumar, A., Rajashree, P., Ramya, R., & Rajkumar, K. (2016) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2016.17.11.4899 · Cited by 59

Correlation between Postoperative Infections and Long-term Survival after Colorectal Resection for Cancer

Nespoli, A., Gianotti, L. V., Totis, M., Bovo, G., Nespoli, L. C., Chiodini, P., & Brivio, F. (2004) · Tumori Journal · doi:10.1177/030089160409000508 · Cited by 58

Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome

Bontkes, H. J., de Gruijl, T. D., Schuurhuis, G. J., Scheper, R. J., Meijer, C. J. L. M., & Hooijberg, E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.321 · Cited by 58

An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer

Sun, Z., Yao, Z., Liu, S., Tang, H., & Xiong, Y. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.11.004 · Cited by 57

T-Cell Tolerance in Cancer

Nurieva, R., Wang, J., & Sahoo, A. (2013) · Immunotherapy · doi:10.2217/imt.13.33 · Cited by 62

Functional modulation of dendritic cells to suppress adaptive immune responses

Woltman, A. M., & van Kooten, C. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902431 · Cited by 56

Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial

Lü, J., Xu, B., Zheng, H., Li, P., Xie, J., Wang, J.-B., Lin, J.-X., Chen, Q., Cao, L., Lin, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49013-6 · Cited by 55

Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis

Nakano, K., Okada, Y., Saito, K., Tanikawa, R., Sawamukai, N., Sasaguri, Y., Kohro, T., Wada, Y., Kodama, T., & Tanaka, Y. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel356 · Cited by 54

CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame

Slager, E. H., Borghi, M., van der Minne, C. E., Aarnoudse, C. A., Havenga, M. J. E., Schrier, P. I., Osanto, S., & Griffioen, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1490 · Cited by 54

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy

Kim, Y., Clements, D. R., Sterea, A. M., Jang, H. G., Gujar, S. A., & Lee, P. C. (2015) · Viruses · doi:10.3390/v7122953 · Cited by 53

A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells

Thakur, A. B., Schalk, D. L., Sarkar, S. H., Al-Khadimi, Z., Sarkar, F. H., & Lum, L. G. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1116-1 · Cited by 52

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

Tel, J., Hato, S. V., Torensma, R., Buschow, S. I., Figdor, C. G., Lesterhuis, W. J., & de Vries, I. J. M. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1189-x · Cited by 49

H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.

Gabrilovich, D. I., Cheng, P., Fan, Y., Yu, B., Nikitina, E., Sirotkin, A., Shurin, M. R., Oyama, T., Adachi, Y., Nadaf, S., et al. (2002) · PubMed · Cited by 51

Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system

Nakamura, I., Shibata, M., Gonda, K., YAZAWA, T., Shimura, T., Anazawa, T., Suzuki, S., Sakurai, K., Koyama, Y., Ohto, H., et al. (2013) · Oncology Letters · doi:10.3892/ol.2013.1231 · Cited by 50

The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression

Li, M., Jiang, P., Wei, S., Wang, J., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113312 · Cited by 52

Insights into CSF-1R Expression in the Tumor Microenvironment

Tomassetti, C., Insinga, G., Gimigliano, F., Morrione, A., Giordano, A., & Giurisato, E. (2024) · Biomedicines · doi:10.3390/biomedicines12102381 · Cited by 51

Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver

Nemunaitis, J. J., Barve, M. A., Orr, D. W., Kuhn, J. A., Magee, M., Lamont, J., Bedell, C., Wallraven, G., Pappen, B. O., Roth, A., et al. (2014) · Oncology · doi:10.1159/000360993 · Cited by 49

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

Dufresne, A., Lesluyes, T., Ménétrier‐Caux, C., Brahmi, M., Darbo, É., Toulmonde, M., Italiano, A., Mir, O., Cesne, A. L., Guellec, S. L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1792036 · Cited by 48

New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk

Zhao, A., Xu, H., Kang, X., Zhao, A., & Lu, L. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.11.001 · Cited by 49

MIP-3α Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity

Bonnotte, B., Crittenden, M. R., Larmonier, N., Gough, M. J., & Vile, R. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4929 · Cited by 49

Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy

Cao, H., Vergé, V., Baron, C. L., Martinache, C., Leon, A., Scholl, S., Gorin, N. C., Salamero, J., Assari, S., Bernard, J., et al. (2000) · Stem Cells and Development · doi:10.1089/152581600319397 · Cited by 49

Melanoma‐derived factors alter the maturation and activation of differentiated tissue‐resident dendritic cells

Hargadon, K. M., Bishop, J. D., Brandt, J. P., Hand, Z. C., Ararso, Y., & Forrest, O. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.58 · Cited by 49

During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-β

Maguer‐Satta, V., Bartholin, L., Jeanpierre, S., Gadoux, M., Bertrand, S., Martel, S., Magaud, J. ‐., & Rimokh, R. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00675-5 · Cited by 48

Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming

Errington‐Mais, F., Jones, J., Merrick, A. E., Bateman, A., Harrington, K. J., Gough, M. J., O’Donnell, D. M., Selby, P. J., Vile, R. G., & Melcher, A. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302609 · Cited by 50

Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Recognizes a Novel Ligand, Mac-2-binding Protein, Characteristically Expressed on Human Colorectal Carcinomas

Nonaka, M., Ma, B. Y., Imaeda, H., Kawabe, K., Kawasaki, N., Hodohara, K., Kawasaki, N., Andoh, A., Fujiyama, Y., & Kawasaki, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215301 · Cited by 48

In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation

Bozhilov, Y. K., Hsu, I., Brown, E. J., & Wilkinson, A. C. (2023) · Cells · doi:10.3390/cells12060896 · Cited by 56

Sensitivity of Dendritic Cells to Microenvironment Signals

Motta, J. M., & Rumjanek, V. M. (2016) · Journal of Immunology Research · doi:10.1155/2016/4753607 · Cited by 47

Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet

Wu, Y., Ho, S.-Y., Nan, F., & Chen, S. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1476-3 · Cited by 47

Advances of MUC1 as a target for breast cancer immunotherapy.

Yang, E., Hu, X. F., & Xing, P. (2007) · PubMed · doi:10.14670/hh-22.905 · Cited by 47

H1° histone and differentiation of dendritic cells. A molecular target for tumor-derived factors

Gabrilovich, D. I., Cheng, P., Fan, Y., Yu, B., Nikitina, E., Sirotkin, A., Shurin, M. R., Oyama, T., Adachi, Y., Nadaf, S., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.285 · Cited by 47

Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies

Sun, C., Dotti, G., & Savoldo, B. (2016) · Blood · doi:10.1182/blood-2015-12-629089 · Cited by 46

Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1ahighCD86−Langerin‐ and CD1a+CD86+Langerin+ phenotypes

Thomachot, M. C., Bendriss‐Vermare, N., Massacrier, C., Biota, C., Treilleux, I., Goddard‐Léon, S., Caux, C., Bachelot, T., Blay, J., & Ménétrier‐Caux, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20146 · Cited by 46

Phenotypic and functional characteristics of monocyte‐derived dendritic cells from patients with myelodysplastic syndromes

Rigolin, G. M., Howard‐Reeves, J., Buggins, A. G. S., Sneddon, C., Castoldi, G., Hirst, W. J. R., & Mufti, G. J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01781.x · Cited by 47

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

Munkácsy, G., Santarpia, L., & Győrffy, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086945 · Cited by 46

Modeling putative therapeutic implications of exosome exchange between tumor and immune cells

Lu, M., Huang, B., Hanash, S., Onuchic, J. N., & Ben‐Jacob, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416745111 · Cited by 45

Leukocyte Infiltration in Cancer Creates an Unfavorable Environment for Antitumor Immune Responses: A Novel Target for Therapeutic Intervention

Bronte, V., Cingarlini, S., Marigo, I., Santo, C. D., Gallina, G., Dolcetti, L., Ugel, S., Peranzoni, E., Mandruzzato, S., & Zanovello, P. (2006) · Immunological Investigations · doi:10.1080/08820130600754994 · Cited by 45

Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor

Liu, C.-C., Wang, Y., Lin, C., Chuang, T.-F., Liao, K., Chi, K.-H., Chen, M.-F., Chiang, H.-C., & Chu, R. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0386-0 · Cited by 45

Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib

Stacchiotti, S., Crippa, F., Messina, A., Pilotti, S., Gronchi, A., Blay, J., & Casali, P. G. (2013) · Clinical Sarcoma Research · doi:10.1186/2045-3329-3-8 · Cited by 45

miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells

Zhang, X., Li, F., Tang, Y., Qinglan, R., Xiao, B., Wan, Y., & Jiang, S. (2020) · Oncogene · doi:10.1038/s41388-020-01406-9 · Cited by 47

Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation

Lo, A. S., Taylor, J. R., Farzaneh, F., Kemeny, D. M., Dibb, N. J., & Maher, J. F. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.010 · Cited by 45

Impairment of Thymus-Dependent Responses by Murine Dendritic Cells Infected with Foot-and-Mouth Disease Virus

Ostrowski, M., Vermeulen, M. E., Zábal, O., Geffner, J. R., Sadir, A. M., & López, O. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3971 · Cited by 45

Immunomodulatory properties of stem cells and bioactive molecules for tissue engineering

Molina, E. R., Smith, B. T., Shah, S. R., Shin, H., & Mikos, A. G. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.038 · Cited by 44

Modification of the tumor microenvironment to enhance immunity

Liao, Y. (2007) · Frontiers in bioscience · doi:10.2741/2336 · Cited by 44

Interplay between dendritic cells and cancer cells

Martínek, J., Wu, T.-C., Cadena, D., Banchereau, J., & Palucka, K. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.07.008 · Cited by 45

Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2

Scholl, S., Squiban, P. J., Bizouarne, N., Baudin, M., Acres, B., von Mensdorff‐Pouilly, S., Shearer, M., Beuzeboc, P., Belle, S. V., Uziely, B., et al. (2003) · BioMed Research International · doi:10.1155/s111072430320704x · Cited by 44

Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy

Kim, J. Y., Kim, Y. J., Kim, J. S., Ryu, H. S., Lee, H. K., Kang, J. S., Kim, H. M., Hong, J. T., Kim, Y. S., & Han, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.009 · Cited by 42

ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion

Bles, N., di Pietrantonio, L., Boeynaems, J., & Communi, D. (2010) · Blood · doi:10.1182/blood-2010-01-265611 · Cited by 42

Increased and Long-Term Generation of Dendritic Cells with Reduced Function from IL-6-Deficient Bone Marrow

Bleier, J. I. S., Pillarisetty, V. G., Shah, A. B., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7408 · Cited by 42

Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression?

Tucci, M., Stucci, L. S., Strippoli, S., Dammacco, F., & Silvestris, F. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0327 · Cited by 42

Immunotherapy of hepatocellular carcinoma

Korangy, F., Höchst, B., Manns, M. P., & Greten, T. F. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.18 · Cited by 41

Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity

Esher, S. K., Fidel, P. L., & Noverr, M. C. (2019) · Journal of Fungi · doi:10.3390/jof5020037 · Cited by 38

An Agonist Antibody Specific for CD40 Induces Dendritic Cell Maturation and Promotes Autologous Anti‐tumour T‐cell Responses in an In vitro Mixed Autologous Tumour Cell/Lymph Node Cell Model

Hunter, T. B., Alsarraj, M., Gladue, R. P., Bedian, V., & Antonia, S. J. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01927.x · Cited by 41

Cytokine production in association with phagocytosis of apoptotic cells by immature dendritic cells

Takahashi, M., & Kobayashi, Y. (2003) · Cellular Immunology · doi:10.1016/j.cellimm.2003.11.008 · Cited by 41

Collagen--a necessary accomplice in the metastatic process.

Nerenberg, P. S., Salsas‐Escat, R., & Stultz, C. M. (2007) · PubMed · Cited by 40

Impact of postoperative complications on long-term outcomes of patients following surgery for gastric cancer: A systematic review and meta-analysis of 64 follow-up studies

Li, J., Zhang, Y., Hu, D., Gong, T.-P., Xu, R., & Gao, J. (2019) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2019.10.007 · Cited by 40

Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands

Idoyaga, J., Moreno, J. G., & Bonifaz, L. C. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0275-y · Cited by 42

Postoperative Complications Influence Prognosis and Recurrence Patterns in Periampullary Cancer

Cho, J. Y., Han, H., Yoon, Y., Hwang, D. W., Jung, K., & Kim, Y. K. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2106-6 · Cited by 39

Phagocytosis, a Potential Mechanism for Myeloid-Derived Suppressor Cell Regulation of CD8+ T Cell Function Mediated through Programmed Cell Death-1 and Programmed Cell Death-1 Ligand Interaction

Kim, Y., Park, S.-J., & Broxmeyer, H. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002650 · Cited by 40

Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells

Li, L., Li, S., Min, J., & Zheng, L. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.09.003 · Cited by 39

A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells

Haegel, H., Thioudellet, C., Hallet, R., Geist, M., Menguy, T., Pogam, F. L., Marchand, J.-B., Toh, M., Duong, V., Calcei, A., et al. (2013) · mAbs · doi:10.4161/mabs.25743 · Cited by 41

Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte–dendritic cell cross-talk

Cabillic, F., Bouet-Toussaint, F., Toutirais, O., Rioux-Leclercq, N. C., Fergelot, P., Pintière, C. T. D. L., Genetet, N., Patard, J. J., & Quémener, V. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03212.x · Cited by 38

Modulation of dendritic cell phenotype and mobility by tumor cells in vitro

Remmel, E., Terracciano, L., Noppen, C., Zajac, P., Heberer, M., Spagnoli, G. C., & Padovan, E. (2001) · Human Immunology · doi:10.1016/s0198-8859(00)00221-4 · Cited by 38

Immune cell networking in solid tumors: focus on macrophages and neutrophils

Ceglie, I. D., Carnevale, S., Rigatelli, A., Grieco, G., Molisso, P., & Jaillon, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341390 · Cited by 38

Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation

Marti, L. C., Pavon, L. F., Severino, P., Sibov, T. T., Guilhen, D. D., & Moreira‐Filho, C. A. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130252 · Cited by 39

Does Postoperative Serum Interleukin-6 Influence Early Recurrence after Curative Pulmonary Resection of Lung Cancer?

Kita, H., Shiraishi, Y., Watanabe, K., Suda, K., Ohtsuka, K., Koshiishi, Y., & Goya, T. (2011) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.10.01627 · Cited by 38

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Montrone, M., Martorelli, D., Rosato, A., & Dolcetti, R. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009788452435 · Cited by 37

Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression

Lopes‐Coelho, F., Gouveia-Fernandes, S., & Serpa, J. (2018) · Tumor Biology · doi:10.1177/1010428318756203 · Cited by 39

Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia

Eisendle, K., Lang, A. H., Eibl, B., Nachbaur, D., Glassl, H., Fiegl, M., Thaler, J., & Gastl, G. A. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03979.x · Cited by 37

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes

Thompson, J. A., Srivastava, M. K., Bosch, J. J., Clements, V. K., Ksander, B. R., & Ostrand‐Rosenberg, S. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0381-5 · Cited by 35

Immune suppression in renal cell carcinoma

Frankenberger, B., Noeßner, E., & Schendel, D. J. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.004 · Cited by 36

IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement

Liu, B., Tan, W., Barsoum, A. L., Gu, X., Chen, K., Huang, W., Ramsay, A. J., Kolls, J. K., & Schwarzenberger, P. O. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.004 · Cited by 36

NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis

Saga, K., Park, J., Nimura, K., Kawamura, N., Ishibashi, A., Nonomura, N., & Kaneda, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1429-z · Cited by 35

Perineural Invasion and Postoperative Complications are Independent Predictors of Early Recurrence and Survival Following Curative Resection of Gastric Cancer

Chen, L., Lin, J., Chen, L., Chen, Y., Wang, X., Guo, Z., & Yu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s264582 · Cited by 35

Immunotherapy of malignant melanoma

Kadison, A. S., & Morton, D. L. (2003) · Surgical Clinics of North America · doi:10.1016/s0039-6109(02)00162-7 · Cited by 35

Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer

Tesone, A. J., Svoronos, N., Allegrezza, M. J., & Conejo-Garcia, J. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00435 · Cited by 35

A survey of herbal medicines as tumor microenvironment‐modulating agents

Park, C., Lee, J., Son, C., & Lee, N. (2020) · Phytotherapy Research · doi:10.1002/ptr.6784 · Cited by 34

Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells

Domagala, M., Laplagne, C., Leveque, E., Laurent, C., Fournié, J., Espinosa, É., & Poupot, M. (2021) · Cancers · doi:10.3390/cancers13020165 · Cited by 36

Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion

Saleem, S. J., & Conrad, D. H. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.010 · Cited by 33

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies

Ye, B., Stary, C. M., Qingping, G., Wang, Q., Zeng, Z. R., Jian, Z., Gu, L., & Xiong, X. (2017) · Journal of Immunology Research · doi:10.1155/2017/5210459 · Cited by 33

Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

Brogden, K. A., Parashar, D., Hallier, A. R., Braun, T. A., Fang, Q., Rizvi, N. A., Bossler, A., Milhem, M. M., Chan, T. A.-T., Abbasi, T., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4134-y · Cited by 33

Mushroomβ-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma

Wang, W.-J., Wu, Y., Chen, S., Liu, C.-F., & Chen, S. (2015) · BioMed Research International · doi:10.1155/2015/604385 · Cited by 35

Suppression of the maturation and activation of the dendritic cell line DC2.4 by melanoma-derived factors

Hargadon, K. M., Forrest, O. A., & Reddy, P. R. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.10.003 · Cited by 33

Dendritic cells heterogeneity and its role in cancer immunity

Kah-Wai, L., Tabarkiewicz, J., & Jacek, R. (2006) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.25847 · Cited by 33

In Melanoma Changes of Immature and Mature Dendritic Cell Expression Correlate with Tumor Thickness: An Immunohistochemical Study

Simonetti, O., Goteri, G., Lucarini, G., Rubini, C., Stramazzotti, D., Muzio, L. L., Biagini, G., & Offidani, A. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000212 · Cited by 33

Tumor-derived factors affecting immune cells

Russo, V. E. A., & Protti, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.005 · Cited by 33

Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case‐control study with propensity score matching

Noji, T., Tsuchikawa, T., Okamura, K., Tanaka, K., Nakanishi, Y., Asano, T., Nakamura, T., Shichinohe, T., & Hirano, S. (2016) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.363 · Cited by 32

Dendritic cells: In the forefront of immunopathogenesis and vaccine development – A review

Mohamadzadeh, M., & Luftig, R. B. (2004) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-2-1 · Cited by 33

CD1a and antitumour immune response

Rocca, G. L., Anzalone, R., Bucchieri, F., Farina, F., Cappello, F., & Zummo, G. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.006 · Cited by 32

Exosomes Derived From Dendritic Cells Infected With Toxoplasma gondii Show Antitumoral Activity in a Mouse Model of Colorectal Cancer

Lu, J., Wei, N., Zhu, S., Chen, X., Gong, H., Mi, R., Huang, Y. H., Chen, Z., & Li, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.899737 · Cited by 31

IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.

Ménétrier‐Caux, C., Thomachot, M. C., Alberti, L., Montmain, G., & Blay, J. (2001) · PubMed · Cited by 83

Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells

Teng, L. L., Chen, Y., Ding, D., Dai, H., Liu, G., & Li, C. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0595-8 · Cited by 25

Defining the molecular mechanisms that control the development of tumor dendritic cells. (66.32)

Tang, M., Diao, J., & Cattral, M. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.186.supp.66.32

Tumor-derived death receptor 6 modulates dendritic cell development

DeRosa, D. C., Ryan, P. J., Okragly, A. J., Witcher, D. R., & Benschop, R. J. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0413-1 · Cited by 28

Suppression of the Development and Function of Dendritic Cells by the Secretion of Tumor Cells

Li, C., Hou, C.-M., Wu, Y., Zhang, S., Zikuan, G., & Mao, N. (2002) · Europe PMC (PubMed Central)